VivoSeq
Other

Volume

0

Pipeline Programs↗

3

Active Trials↗

4

Companies Involved↗

Volume is an early-stage landscape with 0 programs across 4 companies. The most active players are GSK, Merck & Co., Medicines for Malaria Venture.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

GSK logo

GSK

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalMedicines for Malaria Venture logo

Medicines for Malaria Venture

0 programs

PreclinicalNovo Nordisk logo

Novo Nordisk

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

44

clinical trials

Completed30 · 68%
Unknown status5 · 11%
Withdrawn4 · 9%
Terminated2 · 5%
Recruiting2 · 5%
Not yet recruiting1 · 2%

Clinical Trials

Trial Activity

44 trials

Evolution of the Initial Distribution Volume of Glucose in the Severe Burned Adults
Recruiting·—·Phase 2·NCT06469970·15 enrolled
SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia
Recruiting·TThe University of Texas Health Science Center at San Antonio·Phase 1·NCT07053306·29 enrolled
Effect of Balanced Saline Solution and Albumin on Volume Expansion in Shock Patients
Not yet recruiting·PPeking Union Medical College Hospital·Phase 4·NCT05463471·500 enrolled
Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects
Completed·NNorgine·Phase 1·NCT01834742·161 enrolled
The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers
Completed·KKorea University Anam Hospital·Phase 4·NCT00494559·240 enrolled
Closing Volume Interpretation and Bronchodilators Effect
Completed·UUniversity of Milan·Phase 4·NCT01437748·40 enrolled
A Study Evaluating Implementation Strategies for the Delivery of Cabotegravir in Low and High-Volume PrEP Site in the United States
Completed·GSK logoGSK·Phase 4·NCT05374525·287 enrolled
Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes
Completed·QQueen's University·Phase 4·NCT00885430·20 enrolled
ESBA1008 Microvolume Study
Completed·AAlcon Research·Phase 2·NCT01849692·107 enrolled
Comparison of Different HES Coload Volumes on the 90% ED of Norepinephrine
Completed·GGeneral Hospital of Ningxia Medical University·N/A·NCT05712018·90 enrolled
Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume
Completed·IIndonesia University·N/A·NCT04885153·36 enrolled
Respiratory Impact of LA Volume After IS Block
Completed·—·Phase 4·NCT04726280·60 enrolled
Comparison of Low Volume PEG-Asc and Lower Volume PEG-Asc With Bisacodyl
Completed·KKorea University Anam Hospital·Phase 3·NCT02980562·200 enrolled
Volumetric Assessment of Volume Stable Collagen Matrix in Soft Tissue Ridge Augmentation
Completed·—·Phase 1·NCT04873830·20 enrolled
The Effect of Food and Water Volume in Healthy Adult Participants Administered Enlicitide Decanoate (MK-0616) (MK-0616-022)
Completed·Merck & Co. logoMerck & Co.·Phase 1·NCT06658652·34 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)